Taiyen Biotech CoTPE:1737 83 Piotroski F-Score is 7 as of Jul. 11, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,911 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 88.33% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Taiyen Biotech Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Taiyen Biotech Co's Piotroski F-Score or its related term are showing as below:
TPE:1737'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 7
Current: 7
During the past 13 years, the highest Piotroski F-Score of Taiyen Biotech Co was 7. The lowest was 4. And the median was 6.
Taiyen Biotech Co (TPE:1737) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Taiyen Biotech Co Piotroski F-Score Related Terms
Taiyen Biotech Co Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1737 vs PG, CL, KVUE: Piotroski F-Score Comparison
For the Household & Personal Products subindustry, Taiyen Biotech Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Dec25) TTM:
Last Year (Dec24) TTM:
Net Income was 97.281 + 87.139 + 72.36 + 143.087 = NT$400 Mil. Cash Flow from Operations was -42.155 + 202.007 + 116.467 + 155.729 = NT$432 Mil. Revenue was 819.189 + 857.197 + 814.822 + 816.452 = NT$3,308 Mil. Gross Profit was 323.721 + 372.488 + 323.978 + 322.823 = NT$1,343 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was
(8381.173 + 8319.835 + 8371.139 + 8201.101 + 8262.561) / 5 = NT$8307.1618 Mil. Total Assets at the begining of this year (Dec24) was NT$8,381 Mil. Long-Term Debt & Capital Lease Obligation was NT$27 Mil. Total Current Assets was NT$2,756 Mil. Total Current Liabilities was NT$960 Mil.
Net Income was 104.389 + 98.886 + 91.591 + 76.658 = NT$372 Mil.
Revenue was 813.297 + 803.729 + 838.926 + 782.2 = NT$3,238 Mil. Gross Profit was 333.181 + 348.588 + 333.468 + 305.671 = NT$1,321 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was
(8319.743 + 8286.678 + 8364.356 + 8230.071 + 8381.173) / 5 = NT$8316.4042 Mil. Total Assets at the begining of last year (Dec23) was NT$8,320 Mil. Long-Term Debt & Capital Lease Obligation was NT$31 Mil. Total Current Assets was NT$2,927 Mil. Total Current Liabilities was NT$1,165 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Taiyen Biotech Co's current Net Income (TTM) was 400.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Taiyen Biotech Co's return on assets of this year was 0.04771015. Taiyen Biotech Co's return on assets of last year was 0.04465571.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Taiyen Biotech Co's gearing of this year was 0.0031976. Taiyen Biotech Co's gearing of last year was 0.00378625.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Taiyen Biotech Co's current ratio of this year was 2.87141064. Taiyen Biotech Co's current ratio of last year was 2.51248595.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Taiyen Biotech Co's number of shares in issue this year was 202.66. Taiyen Biotech Co's number of shares in issue last year was 202.364.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Taiyen Biotech Co's gross margin of this year was 0.40603024. Taiyen Biotech Co's gross margin of last year was 0.40792032.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Taiyen Biotech Co's asset turnover of this year was 0.39465359. Taiyen Biotech Co's asset turnover of last year was 0.38921298.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
1
+
0
+
0
+
1
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Taiyen Biotech Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Taiyen Biotech Co (TPE:1737) has a Piotroski F-Score of 7 as of Jul. 11, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Taiyen Biotech Co and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Taiyen Biotech Co's Piotroski F-Score has ranged from 4.00 to 7.00. According to the industry distribution chart, Taiyen Biotech Co ranks #223 out of 1911 companies in the Consumer Packaged Goods industry, placing it in the top 11.7%.
Is Taiyen Biotech Co's Piotroski F-Score too high?
Taiyen Biotech Co's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 7.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Taiyen Biotech Co's value of 7 is 40% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #223 out of 1911 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Piotroski F-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #223 out of 1911 companies for Piotroski F-Score. This places Taiyen Biotech Co in the top 12% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Taiyen Biotech Co's value of 7 is 40% above this benchmark. Historically, Taiyen Biotech Co's own Piotroski F-Score has ranged from 4.00 to 7.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,911 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Consumer Packaged Goods industry median of 5.00. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Piotroski F-Score is 7 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 40% above the Consumer Packaged Goods median (#223 of 1911)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
